• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The concept of "fictitious weight" in pharmacokinetic simulations and target-controlled infusion.

作者信息

Obara Shinju

机构信息

Department of Anesthesiology, Center for Pain Management, Surgical Operation Department, Fukushima Medical University Hospital, 1 Hikarigaoka, Fukushima, Fukushima, 960-1295, Japan.

出版信息

J Anesth. 2024 Dec;38(6):733-737. doi: 10.1007/s00540-024-03413-6. Epub 2024 Sep 27.

DOI:10.1007/s00540-024-03413-6
PMID:39333425
Abstract
摘要

相似文献

1
The concept of "fictitious weight" in pharmacokinetic simulations and target-controlled infusion.药代动力学模拟与靶控输注中的“虚拟体重”概念。
J Anesth. 2024 Dec;38(6):733-737. doi: 10.1007/s00540-024-03413-6. Epub 2024 Sep 27.
2
General purpose propofol target-controlled infusion using the marsh model with adjusted weight input.采用调整体重输入的 Marsh 模型的通用丙泊酚靶控输注。
J Anesth. 2024 Apr;38(2):275-278. doi: 10.1007/s00540-024-03312-w. Epub 2024 Feb 11.
3
Comparison of the clinical performance of the modified Marsh model for propofol between underweight and normal-weight patients with Crohn's disease.体重过轻和正常体重的克罗恩病患者之间丙泊酚改良Marsh模型临床性能的比较。
Korean J Anesthesiol. 2017 Dec;70(6):606-611. doi: 10.4097/kjae.2017.70.6.606. Epub 2017 Apr 28.
4
The performance of compartmental and physiologically based recirculatory pharmacokinetic models for propofol: a comparison using bolus, continuous, and target-controlled infusion data.隔室和基于生理的丙泊酚再循环药代动力学模型的性能：使用推注、连续和靶控输注数据的比较。
Anesth Analg. 2010 Aug;111(2):368-79. doi: 10.1213/ANE.0b013e3181bdcf5b. Epub 2009 Oct 27.
5
Performance of target-controlled infusion of propofol using two different pharmacokinetic models in open heart surgery - a randomised controlled study.两种不同药代动力学模型用于心脏直视手术中丙泊酚靶控输注的效果——一项随机对照研究
Perfusion. 2016 Jan;31(1):45-53. doi: 10.1177/0267659115578001. Epub 2015 Apr 15.
6
Predictive performance of the modified Marsh and Schnider models for propofol in underweight patients undergoing general anaesthesia using target-controlled infusion.改良 Marsh 和 Schnider 模型预测在全身麻醉下使用靶控输注的体重不足患者中丙泊酚的预测性能。
Br J Anaesth. 2017 Jun 1;118(6):883-891. doi: 10.1093/bja/aex102.
7
External validation of the modified Marsh and Schnider models for medium-chain triglyceride propofol in target-controlled infusion anesthesia.改良 Marsh 和 Schnider 模型在靶控输注麻醉中用于中链甘油三酯丙泊酚的外部验证。
BMC Anesthesiol. 2024 Feb 23;24(1):70. doi: 10.1186/s12871-024-02461-5.
8
Cross-simulation between two pharmacokinetic models for the target-controlled infusion of propofol.两种丙泊酚靶控输注药代动力学模型的交叉模拟。
Korean J Anesthesiol. 2012 Apr;62(4):309-16. doi: 10.4097/kjae.2012.62.4.309. Epub 2012 Apr 23.
9
TCI : Target controlled infusion, or totally confused infusion? Call for an optimised population based pharmacokinetic model for propofol.靶控输注：是目标控制输注，还是完全混乱的输注？呼吁建立基于人群的丙泊酚优化药代动力学模型。
Ups J Med Sci. 2008;113(2):161-70. doi: 10.3109/2000-1967-222.
10
A pharmacokinetic model optimized by covariates for propofol target-controlled infusion in dogs.一种通过协变量优化的犬丙泊酚靶控输注药代动力学模型。
Vet Anaesth Analg. 2019 Sep;46(5):568-578. doi: 10.1016/j.vaa.2019.04.009. Epub 2019 May 13.

本文引用的文献

1
Involvement of anesthesiologists in pediatric sedation and analgesia outside the operating room in Japan: is it too late, or is there still time?日本麻醉医生参与手术室以外的儿科镇静和镇痛工作：是为时已晚，还是仍有时间？
J Anesth. 2025 Apr;39(2):311-317. doi: 10.1007/s00540-024-03431-4. Epub 2024 Nov 13.
2
Recommendation for the practice of total intravenous anesthesia.全静脉麻醉实践推荐。
J Anesth. 2024 Dec;38(6):738-746. doi: 10.1007/s00540-024-03398-2. Epub 2024 Sep 1.
3
General purpose propofol target-controlled infusion using the marsh model with adjusted weight input.
采用调整体重输入的 Marsh 模型的通用丙泊酚靶控输注。
J Anesth. 2024 Apr;38(2):275-278. doi: 10.1007/s00540-024-03312-w. Epub 2024 Feb 11.
4
How obesity affects the disposition of intravenous anesthetics.肥胖如何影响静脉麻醉药物的处置。
Curr Opin Anaesthesiol. 2023 Aug 1;36(4):414-421. doi: 10.1097/ACO.0000000000001280. Epub 2023 Jun 8.
5
The predictive performance of propofol target-controlled infusion during robotic-assisted laparoscopic prostatectomy with CO pneumoperitoneum in the head-down position.头低脚高位CO2气腹机器人辅助腹腔镜前列腺切除术中丙泊酚靶控输注的预测性能。
J Anesth. 2020 Jun;34(3):397-403. doi: 10.1007/s00540-020-02765-z. Epub 2020 Mar 28.
6
Pharmacokinetic-pharmacodynamic model for propofol for broad application in anaesthesia and sedation.丙泊酚用于麻醉和镇静的广泛应用的药代动力学-药效学模型。
Br J Anaesth. 2018 May;120(5):942-959. doi: 10.1016/j.bja.2018.01.018. Epub 2018 Mar 12.
7
Disposition of Remifentanil in Obesity: A New Pharmacokinetic Model Incorporating the Influence of Body Mass.瑞芬太尼在肥胖人群中的处置：一种纳入体重影响的新的药代动力学模型。
Anesthesiology. 2017 Jun;126(6):1019-1032. doi: 10.1097/ALN.0000000000001635.
8
An Allometric Model of Remifentanil Pharmacokinetics and Pharmacodynamics.瑞芬太尼药代动力学和药效学的异速生长模型。
Anesthesiology. 2017 Jun;126(6):1005-1018. doi: 10.1097/ALN.0000000000001634.
9
Performance of propofol target-controlled infusion models in the obese: pharmacokinetic and pharmacodynamic analysis.丙泊酚靶控输注模型在肥胖患者中的性能：药代动力学和药效学分析。
Anesth Analg. 2014 Aug;119(2):302-310. doi: 10.1213/ANE.0000000000000317.
10
Predictive performance of the 'Minto' remifentanil pharmacokinetic parameter set in morbidly obese patients ensuing from a new method for calculating lean body mass.预测肥胖患者使用新型瘦体量计算方法得出的“Minto”瑞芬太尼药代动力学参数集的表现。
Clin Pharmacokinet. 2010;49(2):131-9. doi: 10.2165/11317690-000000000-00000.